Home » Topics » Immune, BioWorld Science

Immune, BioWorld Science
RSS

Alpha-Beta Technology's Betafectin shows efficacy in phase III trial

Aug. 6, 1997

Procept awarded grant for tuberculosis vaccine research

Aug. 5, 1997

Vertex acquires ICE patent portfolio from Sanofi

Aug. 5, 1997

Novel immunomodulating agents from Gruenenthal

July 31, 1997

Cypros licenses patents for CPC-111 in organ transplant

July 30, 1997

New emulsion formulation of tacrolimus provides local immunosuppression

July 30, 1997

SangStat Medical reports encouraging phase III results with Thymoglobulin

July 29, 1997

DynaGen expands ImmuDyn development

July 24, 1997

Mycophenolic acid derivatives with immunosuppressive activity claimed

July 17, 1997

Intranasal flu vaccine effective and safe in children

July 16, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...